Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from TherapeuticsMD ( (TXMD) ) is now available.
TherapeuticsMD, Inc. reported a reduced net loss for Q3 2024, with operating expenses also declining due to its shift to a royalty-based business model. The company is exploring strategic alternatives, including potential mergers or acquisitions, but has not committed to any specific actions. Their cash reserves stand at $5 million, as they continue to focus on maximizing shareholder value amid a volatile stock environment.
See more data about TXMD stock on TipRanks’ Stock Analysis page.